News archive

Antibiotic resistance: The last resort Health officials are watching in horror as bacteria become resistant to powerful carbapenem antibiotics — one of the last drugs on the shelf.  

The National Natural Science Foundation of China (NSFC) and the Swedish Research Council (SRC) sponsored a workshop in Beijing on May 15-17, 2013 to promote the exchange and collaboration between the Chinese and Swedish antibiotics resistance research communities. About 20 scientists from the two countries participated in this event that addressed antibiotics and their use […]

https://www.jpiamr.eu/organisation/stakeholders-forum/  

The current strategic research agenda (SRA) draft will be further developed according to the input and outcomes of the May 27-28 Geneva invitational conference. The resulting new draft will be made available to the public at this website no later than September 1, 2013. The research and stakeholder communities are most welcome to comment the […]

The JPIAMR Invitational Conference to discuss the strategic research agenda (SRA) was held in Geneva on May 27 and 28. Members from the management board, scientific advisory board and stakeholder advisory board, as well as additional experts, met for group and plenary discussions. The constructive discussions have provided the SRA writers with a wealth of […]

An invitational conference will be held in Geneva on May 27-28.The main discussion topic will be the latest draft of the strategic research agenda (SRA). All members of the management board, the scientific advisory board and the stakeholder advisory board are invited, along with some additional experts.

Stakeholder involvement will be crucial for the process of first developing and then implementing a strategic research agenda (SRA). A first stakeholder advisory board (SHAB) meeting was held at the Romanian Office for Science and Technology in Brussels on April 18 with representatives from Action on Antibiotic Resistance (ReACT), European Federation of Pharmaceutical Industries Associations […]

In the February issue of The Lancet Infectious Diseases Herman Goossens, chairman of JPIAMR’s scientific advisory board, comments on “The Chennai Declaration—a roadmap to tackle the challenges of antimicrobial resistance in India”. See also:The Chennai Declaration (Indian Journal of Cancer)

The Innovative Medicins Initiative (IMI) launched its 8th call for proposals.Topics included under the IMI programme “Combating Antibiotic Resistance: New Drugs for Bad Bugs” are: Topic 1C: Innovative Trial Design & Clinical Development Topic 3: Discovery and development of new drugs combating Gram – negative infections Dealine for submitting a proposal is 19 March 2013. Link: […]

The Swedish government allocates a total of SEK 265 million over four years for research on infection and antibiotics. The initiative was announced in the Research and Innovation bill of 2013, outlining the Swedish government’s research policy and funding for 2013-2016. In the bill, the Swedish government further states that: “To strengthen the international competitiveness of Swedish research, […]